HPV Ends Here: Increasing Uptake of the HPV Vaccine
ConditionHPV Vaccine
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-12
SponsorUniversity of California, Davis
About this trial
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Intervention Arm
Treatment groups
2,232 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, Davis
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov